Hanstedt, Germany

Bruno Steinkraus

This inventor holds 1 USPTO granted patent and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Hummingbird Diagnostics Gmbh. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bruno Steinkraus: Innovator in RNA Detection Technology

Introduction

Bruno Steinkraus is a notable inventor based in Hanstedt, Germany. He has made significant contributions to the field of molecular biology, particularly in the detection of small non-coding RNAs. His innovative approach has the potential to advance research in various biological applications.

Latest Patents

Bruno Steinkraus holds a patent for an invention titled "Advanced Dumbell PCR for isomiR detection." This invention relates to a method for detecting small non-coding RNAs in a sample using sequence-specific structured adapters for ligation by a double-stranded RNA ligase. The process includes subsequent cDNA production and quantification. Additionally, the invention encompasses a kit designed for carrying out this method. He has 1 patent to his name.

Career Highlights

Bruno Steinkraus is associated with Hummingbird Diagnostics GmbH, where he applies his expertise in molecular diagnostics. His work focuses on developing innovative solutions that enhance the accuracy and efficiency of RNA detection.

Collaborations

Some of his notable coworkers include Rastislav Horos and Carla Bieg-Salazar. Their collaborative efforts contribute to the advancement of research and development in the field of diagnostics.

Conclusion

Bruno Steinkraus is a pioneering inventor whose work in RNA detection technology is making a significant impact in molecular biology. His contributions are paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…